Select Medical Holdings CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Select Medical Holdings Corporation announces its 2026 Annual Meeting of Stockholders to address director elections, executive compensation, auditor ratification, board declassification, and special meeting rights.
NYSE
Select Medical Holdings Corporation amends its definitive proxy statement to clarify the effect of broker non-votes on Proposal 3.
NYSE
Select Medical Holdings Corporation will hold its annual stockholder meeting virtually on April 24, 2025, to vote on key proposals including director elections and executive compensation.
NYSE
Select Medical Holdings Corporation will hold its 2025 Annual Meeting of Stockholders virtually on April 24, 2025, to vote on director elections, an amendment to eliminate supermajority voting, director compensation policy, and other proposals.
NYSE
DEFR14A: Select Medical Holdings Corrects Proxy Statement Regarding Share Count and Broker Non-Votes
Select Medical Holdings Corporation amends its definitive proxy statement to correct the number of outstanding shares eligible to vote and clarify the effect of broker non-votes on certain proposals.
NYSE
Select Medical Holdings Corporation will hold its annual stockholder meeting virtually on April 25, 2024, to vote on director elections, executive compensation, equity incentive plan amendments, auditor ratification, officer exculpation, and a stockholder proposal.
NYSE
Select Medical Holdings Corporation's upcoming annual meeting will address key proposals, including director elections, executive compensation, and an amendment to exculpate officers from certain liabilities.